By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Where Great Emphasis is Put on Research.

Evotec SE

„In April 2020, we opened up a new facility for gene therapy in Orth an der Donau in Austria, namely Evotec Gene Therapy (Evotec GT). In this way, we complemented a further important building block in our active substance research platform. In order to be an ideal partner for research and development of new medicines, we have to technologically encompass all possible active ingredient types such as small molecules, biologics and also gene therapies. For this reason, our gene therapy site in Austria comprises an important lane on our development highway designed to support our long-term growth path."

Dr. Werner Lanthaler, Chief Executive Officer of Evotec SE

With its workforce of more than 3,400 employees, the company offers its customers around the world high-quality, independent and integrated solutions in active substance research, from target to clinical development. An experienced team of gene therapy experts will work at the new R&D site in Lower Austria. At the same time, the new facility has entered into a long-term research alliance with Takeda in order to support a growing number of gene therapy research programmes.

Evotec SE

Evotec SE

Hinnerk Rohwedder,
Corporate Communications Associate

Tel.: + 49 (0)40 56081-281

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • Austria – Carinthia your ICT Hub in the Heart of Europe

    14.04.2021/ 02.30 pm (India Time) , Online Conference

Austria Map

Find the perfect location for your company

Austria is well known for its social stability and excellent labor relations where strikes are measured only in seconds. As a global player, reliable deliveries are a top priority for us.

Opel Austria

More testimonials

news from the business location Austria

Austrians conduct research in New York on low-priced vaccine

Two Austrians are conducting research in New York on a vaccine against the coronavirus which is designed to be available at a particularly low price and also be easy to dispense.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts